When.com Web Search

  1. Ad

    related to: glucagon dosing for food impaction

Search results

  1. Results From The WOW.Com Content Network
  2. Esophageal food bolus obstruction - Wikipedia

    en.wikipedia.org/wiki/Esophageal_food_bolus...

    An esophageal food bolus obstruction is a medical emergency caused by the obstruction of the esophagus by an ingested foreign body.. It is usually associated with diseases that may narrow the lumen of the esophagus, such as eosinophilic esophagitis, Schatzki rings, peptic strictures, webs, or cancers of the esophagus; rarely it can be seen in disorders of the movement of the esophagus, such as ...

  3. Glucagon (medication) - Wikipedia

    en.wikipedia.org/wiki/Glucagon_(medication)

    Glucagon, sold under the brand name Baqsimi among others, is a medication and hormone. [9] As a medication it is used to treat low blood sugar , beta blocker overdose , calcium channel blocker overdose , and those with anaphylaxis who do not improve with epinephrine . [ 10 ]

  4. Glucagon receptor agonist - Wikipedia

    en.wikipedia.org/wiki/Glucagon_receptor_agonist

    [3] [4] In healthy people, a low dose of exogenous glucagon increases energy expenditure and reduces energy intake without causing hyperglycemia. [2] Glucagon is often elevated in type 2 diabetes ; [ 3 ] glucagon receptor antagonists were developed for the treatment of this disease but most were abandoned due to safety and adverse effects.

  5. Foreign body in alimentary tract - Wikipedia

    en.wikipedia.org/wiki/Foreign_body_in_alimentary...

    Glucagon has been used to treat esophageal foreign bodies, with the intent that it relaxes the smooth muscle of the lower esophageal spincter to allow the foreign body to pass into the stomach. [10] However, evidence does not support a benefit of treatment with glucagon, and its use may result in side effects.

  6. GLP1 poly-agonist peptides - Wikipedia

    en.wikipedia.org/wiki/GLP1_poly-agonist_peptides

    GLP1 poly-agonist peptides [1] are a class of drugs that activate multiple peptide hormone receptors including the glucagon-like peptide-1 (GLP-1) receptor.These drugs are developed for the same indications as GLP-1 receptor agonists—especially obesity, type 2 diabetes, and non-alcoholic fatty liver disease.

  7. Glucagon - Wikipedia

    en.wikipedia.org/wiki/Glucagon

    n/a Ensembl n/a n/a UniProt n a n/a RefSeq (mRNA) n/a n/a RefSeq (protein) n/a n/a Location (UCSC) n/a n/a PubMed search n/a n/a Wikidata View/Edit Human Glucagon is a peptide hormone, produced by alpha cells of the pancreas. It raises the concentration of glucose and fatty acids in the bloodstream and is considered to be the main catabolic hormone of the body. It is also used as a medication ...

  8. Blood sugar regulation - Wikipedia

    en.wikipedia.org/wiki/Blood_sugar_regulation

    If the blood glucose level falls to dangerously low levels (as during very heavy exercise or lack of food for extended periods), the alpha cells of the pancreas release glucagon, a peptide hormone which travels through the blood to the liver, where it binds to glucagon receptors on the surface of liver cells and stimulates them to break down glycogen stored inside the cells into glucose (this ...

  9. Glucagon rescue - Wikipedia

    en.wikipedia.org/wiki/Glucagon_rescue

    The purpose of the off-label 'mini-dose' is to avoid an emergency condition that may require glucagon rescue. This might be needed in cases such as when a diabetic child is injected with insulin before breakfast, eats, and then vomits and cannot eat again: with the injected insulin working its way into the bloodstream and no carbohydrate to balance, there may soon be a hypoglycemic emergency.